Sarah Khan edited untitled.tex  almost 9 years ago

Commit id: 2494641b1b93240f7520e478f2c425e701810e4f

deletions | additions      

       

ineligible articles. Quality and risk of bias assessment was completed in 91 (50%) of articles assessed. Most common tools used were those that were of some unique method created by the author (27.47%,n=25) and those independently assessed by authors (20.88%, n=19). In assessing risk of bias, high/medium/low scale was used most (18.97%, n=11), and quality was assessed through author created scales (29.31%, n=17).  \subsection{\textbf{Conclusions:}}  Quality and risk of bias were assessed in half of the systematic reviews and meta-analyses coded, however methods of assessment are determined by authors independently rather than following well known scales such as Jadad and Newcastle-Ottawa Scale.High risk of bias and low quality studies were included in most of these studies.This analysis provides further evidence of the lack of consistency in reporting quality measures for clinical findings in the field of oncology. Differences between assessment of bias and quality reporting could negatively impact the clinical application of findings in oncology journals.  Keywords: \subsection{\textbf{Keywords:}}  bias;meta-analysis;oncology;quality;systematic review \section{Introduction}